Date: 2015-01-12
Type of information: Distribution agreement
Compound: METAscreen® kits
Company: METAFORA biosystems (France) Ozyme (France)
Therapeutic area: Technology - Services
Type agreement: distribution
Action mechanism:
Disease:
Details: * On January 12, 2015, Metafora biosystems announced the signature of a distributorship agreement with Ozyme to commercialize its newly developed series of METAscreen® kits for research. Ozyme granted exclusive sales rights in France and non-exclusive in European Union.
Financial terms:
Latest news:
